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ABSTRACT 
 
Integrin adhesion molecules have important adhesion and signaling functions. They also play a central role in the pathogenesis of many 
autoimmune diseases. Over the past few years we have described a T cell adoptive transfer model to investigate the role of T cell 
integrin adhesion molecules in the development of autoimmunity. This report summarizes the methods we used in establishing this 
murine model. By treating murine CD4+ T cells with DNA hypomethylating agents and by transfection we were able to test the in vitro 
effects of integrin overexpression on T cell autoreactive proliferation, cytotoxicity, adhesion and trafficking. Furthermore, we showed 
that the ability to induce in vivo autoimmunity may be unique to the integrin lymphocyte function associated antigen-1 (LFA-1).  
 
 
INTRODUCTION 
 
Integrin adhesion molecules are a family of heterodimers formed 
by two covalently linked α and β glycoprotein chains (1, 2). 
Selected integrins are expressed on T cells. These include LFA-1 
(CD11a/CD18, αLβ2), very late activation antigen-4 (VLA-4, 
CD49d/CD29, α4β1), lymphocyte Peyer's patch adhesion 
molecule-1 (LPAM-1, CD49d/β7, α4β7) and αvβ3 
(CD51/CD61). The integrins are best known for their central 
role in the arrest and transmigration of leukocytes to sites of 
inflammation and immune response. In addition, they also act as 
co-stimulatory molecules involved in the bi-directional signaling 
into and out of T cells (3, 4). Interactions between integrins and 
their receptor ligands have important consequences and can lead 
to T cell tyrosine phosphorylation (5), cytokine production (6, 7), 
cellular proliferation (6, 7) or cell death (8). 
 
T cell integrins may also play a role in the pathogenesis of 
autoimmune diseases. For example, patients with lupus have T 
cell subsets that overexpress LFA-1. These LFA-1-
overexpressing T cells are also autoreactive and will proliferate in 
response to autologous antigen presenting cells alone without 
specific antigen or mitogen (9, 10). Interestingly, the subset of 
lupus patients with vasculitis also has T cells that overexpress the 
CD49d integrin (10). However, the pathogenic significance of 
these autoreactive T cells is unclear. We recently investigated the 
consequence of T cell integrin overexpression by drug treatment 
and transfection. We showed that LFA-1 overexpression 
correlates to the development of in vitro autoreactivity and in vivo 
autoimmunity. In contrast, although CD49d overexpression 
resulted in similar T cell autoreactive proliferation, these cells 
were incapable of inducing in vivo autoimmunity. The methods we 
used and the results are summarized below (Table 1). 
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MATERIALS AND METHODS 
 
Mice 
 
AKR/J and B10.A mice were purchased from Jackson laboratory 
(Bar Harbor, ME) at 6-8 weeks of age. Older AKR mice were not 
used as these mice have a high incidence of lymphoma by the 
time they are 12 months old (11). Oophorectomy, orchiectomy 
and splenectomy were performed on AKR/J mice at Jackson 
laboratory. The mice were allowed to recover for at least 4 weeks 
before they were used for any of the experiments. For the 
hormone replacement experiments, β-estradiol (60-day release, 
0.36 mg/pellet achieving blood level of 150-200 pg/ml), 
progesterone (60-day release, 25 mg/pellet achieving blood level 
of 15-20 ng/ml) or placebo pellets (all from Innovative Research 
of America, Sarasota, FL) were implanted under the skin on the 
lateral side of the neck of the animals. Experiments were done on 
the mice 2-3 weeks after the pellets had been implanted. 
 
T cell culture 
 
D10.G4.1, a conalbumin-reactive cloned T-helper (Th) 2 cell line, 
was obtained from the American Type Culture Collection 
(Rockville, MD). The cells were cultured in Click’s medium 
(Sigma, MO) supplemented with 10% fetal calf serum (FCS), 
40% interleukin (IL)-2 containing conditioned media, 2 mM 
glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 5 
x 10-5 M 2-mercaptoethanol. The cells are maintained by weekly 
challenging with irradiated (3,000R) AKR/J splenocytes and 
conalbumin (100 µg/ml). Because of a report (12) that the D10 
line may contain an autoreactive subset we first subcloned the 
cells by limiting dilution at 0.2 cells/well. In addition, we find 
that chronic culture of D10 cells can also result in the emergence 
of an autoreactive line. We therefore checked for T cell 
autoreactivity by proliferation assay every 4-6 weeks. We also did 
not use D10 cells that have been cultured for more than 2-3 
months. AE7 cells, a pigeon cytochrome C-reactive Th1 line was 
obtained from Dr. Ronald Swartz (National Institute of Health) 
and cultured in the same media as D10 cells except the Click’s 
media was replaced with 50% Click’s and 50% RPMI media. The 
AE7 cells were challenged weekly with irradiated B10.A 
splenocytes and pigeon cytochrome C (100 µg/ml). 
 
Primary endothelial cell culture 
 
Microvascular endothelial cells were isolated according to a 
previously published protocol (13). Mouse ears from 3-4 weeks 
old female AKR mice were split into two and incubated in 0.5% 
Dispase II (Boehringer Mannheim, Germany) in phosphate 
buffered solution (PBS) (Gibco BRL) at 37oC for 1 hour. The 
dermal layer was then dissected away from the epidermal layer 
under a dissecting microscope. Microvascular endothelial cells 
were scraped off from the dermal layer using the blunt end of a 
scalpel. The cells were then allowed to grow on 1% gelatin-
coated sterile petri dish in RPMI (Gibco BRL) media with 
Fungizone (260 mg/ml) (Gibco BRL), endothelial cell growth 
supplement (Collaborative Biomed, Bedford, MA), and FCS. 
Passage 2 (P2) cells on day 10 were used. Identity of the 
endothelial cells was confirmed by their cobblestone morphology, 
uptake of fluorescent-labeled acetylated low density lipoprotein 
(1,1'-diotadecyl-3,3,3',3'-tetramethyl-indo-carbocyanine 
perchlorate, DiI-Ac-LDL), expression of Von Willibrand factor 
(VWF) and CD34.  
 
Drug treatment protocols 
 
In mammalian cells, methylation of DNA helps stabilize 
chromatin in an inactive configuration and inhibits gene 
transcription (14-16). A number of DNA hypomethylating agents 
are capable of inducing T cell LFA-1 overexpression and major 
histocompatibility complex (MHC)-specific autoreactive 
proliferation, most likely via inhibition of the DNA 
methyltransferase 1 (Dnmt1) enzyme (17-20). Because dividing T 
cells are required, the cells were treated 24 hours after challenging 
with 1-2.5 µM 5-azacytidine, 25-50 µM procainamde, 25-50 µM 
N-acetylprocainamde, 5-50 µM hydralazine or 5-50 µM 
phthalazine (all from Sigma-Aldrich, MO).  
 
Adoptive transfer protocol 
 
6 weeks old AKR and B10.A mice were used for the D10 and 
AE7 cells adoptive transfer experiments respectively. The 
protocol we used is based on the CD4+ T cell adoptive transfer 
murine chronic-graft-versus-host model (21, 22). The drug-
treated D10 and AE7 cells and the transfectants were washed, 
dead cells removed by centrifugation through Lympholyte M 
(Hornby, Ontario, CA). 5 x 106 viable cells were suspended in 0.1 
ml sterile PBS and injected into the tail vein of syngeneic mice, 
using a 26 gauge needle every two weeks for a total of 6 
injections. The rationale for repeated adoptive transfers derives 
from the observation that drug-induced autoreactivity is self-
limited (19). 4 weeks after the last injection the mice were 
euthanized and studied for the development of serologic and 
histologic evidence of autoimmunity. 
 
Generation of pSub2-CD18 and pSub2-CD49d 
constructs 
 
The mammalian expression vector pSub2 containing the 
neomycin-resistant cassette was donated by Dr. Mike Clarke 
(University of Michigan, MI). The pSub2 polylinker site was 
cleaved with EcoRV, and EcoR1(NotI) adapters (GIBCO BRL, 
Gaithersburg, MD) ligated to the blunt ends. The 2.8 kb murine 
CD18 cDNA and 4 kb murine CD49d cDNA plasmids were 
donated by Dr. Raymond Wilson (Baylor College of Medicine, 
TX) and Dr. Irving Weissman (Stanford University, CA) 
respectively. Sense and anti-sense CD18/pSub2 and 
CD49d/pSub2 constructs were then made by cloning the 
fragments into the NotI adaptor sites. The constructs were 
linearized by digestion with ScaI and D10 cells transfected by 
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electroporation (250 V and 960 mu F). Stable transfectants were 
selected and maintained by culturing in media containing 250 
µg/ml Geneticin (G418) (GIBCO BRL). Finally, the 
transfectants were subcloned by limiting dilution at < 0.2 
cells/well.  
 
Southern blot analysis 
 
Southern blot analyses of the transfectants and control D10 cells 
were performed. Briefly, 20-30 µg of genomic DNA from the 
cells was digested overnight with NotI restriction enzyme at 37oC 
and resolved by 1% agarose gel before being transferred to nylon 
membranes (MagnaGraph; Micro Separations, Inc., 
Westborough, MA). The filters were hybridized with 32P-labeled 
(Genius system; Boehringer Mannheim) full length CD18 or 
CD49d cDNA, excised from pSub2 with Not1, and exposed to 
x-ray film. 
 
Flow cytometric analysis 
 
Transfectants and control cells were allowed to react with 
monoclonal antibodies (mAbs) conjugated with FITC or PE 
including anti-CD3, -T cell receptor (TCR), -CD18, -CD28, -
CD29, -β7, -CD49d, -CD62L, -CD49d/β7 (DATK32) (BD 
PharMingen) and goat anti-mouse immunoglobulin (Ig) (Coulter 
Corp., Hialeah, FL) and analyzed by a Coulter ELITE flow 
cytometer.  
 
Proliferation assays 
 
104 drug-treated D10 cells, AE7 cells or transfectants were co-
cultured with 103-104 irradiated syngeneic splenocytes (antigen 
presenting cells) with or without 100 µg/ml conalbumin (D10) or 
pigeon cytochrome C (AE7) for 4 days in culture media lacking 
IL-2 using round bottom microtiter plates. Proliferation was 
measured by 3H-labeled TdR incorporation. For the inhibition 
studies, the T cells were preincubated with mAbs against CD49d, 
CD29, β7, CD18, Iak, Iab/d or control Ig antibodies for 30 
minutes at 37oC, washed x3 with RPMI, before co-culturing with 
the antigen presenting cells. 
 
Cytotoxicity assays 
 
Peritoneal macrophages were obtained by injecting 2 ml 
thioglycolate solution into the peritoneal cavity of 6 weeks old 
AKR or B10.A mice. Two days later the cells were collected by 
washing the peritoneal cavity with 10 ml PBS. The cells were 
then labeled with 100 µCi [51Cr]-Na2Cr2O7 (New England 
Nuclear, Boston, MA)/107 cells in 1 ml solution. Cytotoxicity 
assays were done by co-culturing the drug-treated or transfected 
D10 cells with the 51CR-labeled peritoneal macrophages as target 
cells for 18 hours in culture media lacking IL-2. The 
effector:target cell ratio used was between 5-10:1. Percent 
cytotoxicity was calculated as [(experimental – background 
release)/(total incorporation – background release)] X 100. 
ELISA assays 
 
Serum immunoglobulins and autoantibodies were measured using 
Immulon 4 plates (Dynatech Laboratories) coated with 2.5 µg anti-
mouse IgG, IgM (Sigma), purified ssDNA (Sigma) or dsDNA 
(cesium chloride-purified KS+-SV2CAT plasmid) in 100 µl 0.01M 
PBS, pH 7.4 for 18 hours at 4oC. The plates were washed x 3 with 
PBS containing 0.05% Tween 20, then 200 µl of PBS 
supplemented with 3% BSA, 0.1% gelatin and 0.05% Tween 20 
were added and incubated 2 hours at room temperature. Samples 
or Ig standards were diluted to the desired concentrations in PBS 
containing 3% BSA and 0.1% gelatin, added to the wells and 
incubated 18 hours at 4oC, then washed x 3. 100 µl horseradish 
peroxidase (HRP)-conjugated goat anti-mouse Ig was added at a 
final dilution of 1:2500 in PBS containing 0.05% Tween 20 and 
incubated for 2 hours at room temperature. Pooled sera from 6 
month old female NZB/NZW mice or 5 month old female 
MRL/lpr mice were used as positive controls. The plates were 
developed using Sigma Fast tablets (Sigma) according to the 
manufacturer's instructions. 
 
Static and flow adhesion assays 
 
Endothelial cells were grown to 90% confluence in 1% gelatin-
coated 24-well plate (Costar). Transfectants and control D10 cells 
were labeled with 51Cr by culturing 10 x 106 cells with 100 µCi 
[51Cr]-Na2Cr2O7 (New England Nuclear, Boston, MA) in 1 ml at 
37oC for 1 hour. The cells were washed 3 times with RPMI 1640 
(Gibco, Grand Island, NY). The 51Cr-labeled D10 cells were then 
allowed to adhere to the endothelial cell monolayer for 30 mins at 
37oC. The non-adhered cells were removed by washing x3 with 
RPMI 1640. The adhered cells were then lyzed with NP-40, and 
radioactivity counted by a beta counter. For the functional 
blockade experiments, the CD49d-transfected D10 cells were 
preincubated with either anti-CD49d or control Ig antibodies for 
30 minutes at 37oC, washed x3 with RPMI, before adhesion to 
the endothelial cells. 
 
The parallel-plate flow chamber used in the flow adhesion assays 
has been described previously in detail (23, 24). Briefly, the 
chamber is composed of two stainless steel plates separated by a 
Silastic gasket (250 µm thickness, Dow Corning). The flow 
channel was formed by removal of a 5.0 x 50.0 mm rectangular 
section from the Silastic gasket. Defined levels of flow were 
applied to the endothelial cell monolayer by drawing the 
perfusion medium (PBS containing 0.7 mmol/L Ca2+, 0.7 
mmol/L Mg2+, and 0.2% fetal calf serum) through the channel 
using a syringe pump (model 44, Harvard Apparatus). A copper 
heating plate with two electrical heating cartridges (SC12-1, 
Hotwatt) was mounted on the top of the chamber to maintain 
temperature at 37oC. The channel flow can be approximated as 
two-dimentional fully developed laminar flow with a simple 
parabolic velocity profile, since the channel height is a linear 
function of the volume flow rate through the channel. 
Microvascular endothelial monolayers on coverslips were 
stimulated with TNF-α (2.5 ng/ml) for 16 hours at 37oC, 
Yung et al.   
 
 
Biological Procedures Online • Vol. 5 No. 1 • October 24, 2003 • www.biologicalprocedures.com 
214
positioned in the flow chamber, and mounted on an inverted 
microscope equipped with 10x and 40x phase contrast objectives. 
A circular glass window in the top plate allowed direct 
examination of the monolayer during the experiment. The 
monolayer was perfused for 5 to 10 minutes with perfusion 
medium to verify that the monolayer was confluent and intact. 
106 cells/ml perfusion medium of the CD49d-transfected and 
untransfected D10 cells were drawn through the chamber at 2.0 
dyne/cm2 for 5 minutes, then decreased to 0.2 dyne/cm2 for 5 
minutes. Leukocyte adhesion was determined by counting the 
number of T cells in 20 randomly selected high-power 
microscope fields during the final minute at each level of flow. 
 
Western blots 
 
D10 cells and transfectants were stimulated with anti-CD3 (10 
mg/ml) for 10 minutes and crosslinked with goat anti-rat IgG. 
Proteins from the cells were resolved on 10% SDS-
polyacrylamide gel and transferred to nitrocellulose-1 membrane. 
The membrane was then incubated with horse radish peroxidase 
(HRP) conjugated anti-phosphotyrosine antibody (Chemicon 
International, CA) and anti-mouse IgG (Chemicon International). 
Detection was performed using the ECL system (Amersham Life 
Science) according to the manufacturer’s instructions. The 
membrane was stripped and probed with control anti-β-actin 
antibodies (Chemicon International). 
 
Measurement of intracellular calcium 
 
D10 cells and transfectants were suspended in RPMI, 2% FBS, 
25 mM HEPES (pH 7.4) and loaded with 1.5 mM Indo-1 for 45 
minutes at 37oC in the dark, then washed twice with DMEM, 2% 
FBS and resuspended in RPMI, 2% FBS, 25 mM HEPES (pH 
7.4) and stored in the dark at room temperature until 1 hour 
before analysis. Cells were then diluted to 1 x 106/ml with RPMI, 
2% FBS, 25 mM HEPES, and allowed to equilibrate at 37oC, in 
the dark for 30-60 minutes. Cells were then incubated with 10 
µg/ml of the indicated mAb for 1-5 minutes and then cross-
linked with anti-rat IgG, and calcium release immediately 
analyzed by flow cytometry. Ionomycin (1 µg/ml) was used as a 
positive control. 
 
In vivo T cell splenic homing 
 
Drug-treated and transfected D10 cells were labeled with 
CellTracker™ Green 5-chloromethylfluorescein diacetate 
(CMFDA) (Molecular Probes, Eugene, OR), carboxyfluorescein 
diacetate, succinimidyl ester (CDFA-SE) (Molecular Probes) or 
PKH26 green fluorochrome (Sigma, St. Louis, MO) using the 
protocols provided by the manufacturers. Viability of the cells 
was determined by trypan blue exclusion and was similar in the 
labeled and unlabeled cells. 5-10 x 106 labeled cells were injected 
intravenously via the tail vein, and the mice were euthanized 24 
hours later. Labeled D10 cells were detected by staining 
splenocytes with FITC or phycoerythrin (PE)-conjugated anti-
CD4, then enumerating cells expressing both CD4 and CMFDA 
or CDFA-SE with a Coulter ELITE flow cytometer. For 
controls, D10 homing to the lungs was also determined. Briefly, 
the lungs were perfused in situ using normal saline to clear the 
pulmonary vasculature, and then the cells in the airways and 
alveolar spaces were collected by bronchoalveolar lavage. The 
lavaged lungs were then dissected free of extrapleural lymphatic 
tissue and finely minced and enzymatically digested (collagenase 
plus DNase). The cells were then washed and the D10 cells 
enumerated as for the spleen cells. 
 
RESULTS AND DISCUSSION 
 
Characterization of drug-treated and CD18, CD49d 
transfectants 
 
Previous works using flow cytometric staining and 2-dimensional 
protein gel analysis have shown that expression of only a few T 
cell surface antigens, including LFA-1, are changed following 
treatment with DNA hypomethylating agents (9). To directly test 
the functional consequence of T cell LFA-1 overexpression, a 
murine CD18 construct (CD18/pSub2) was transfected into D10 
cell. The stably transfected D10 cells exhibited a 10-fold increase 
in LFA-1 expression (both the CD11a and CD18 chain) (25). To 
determine if overexpression of other β integrins has similar 
functional consequence we substituted the CD18 cDNA with a 
murine CD49d cDNA and transfected the construct 
(CD49d/pSub2) into D10 cells. The CD49d D10 transfectants 
also had a roughly 10-fold increase in CD49d surface expression 
(26). Interestingly, and for unclear reason, the corresponding β7 
but not β1 (CD29) chain was similarly increased in the CD49d 
transfected D10 clones tested (Fig. 1). Flow analyses confirmed 
that upregulation of CD49d did not affect CD18, CD28, CD4, 
CD62L or T-cell receptor expression. 
 
Murine CD4+ cells become autoreactive following 
treatments with DNA hypomethylating agents or 
transfection with CD18, CD49d 
 
To establish a murine model of drug-induced autoimmunity, we 
first determined if murine CD4+ T cells respond to DNA 
demethylating agents, including 5-azacytidine, procainamide and 
hydralazine, in a similar way as their human counterparts. Our 
results showed that drug-treated murine polyclonal (28), cloned 
Th1 (AE7) (29) and cloned Th2 (D10) (25, 28-30) CD4+ T cells 
also overexpressed LFA-1 and proliferated to normally 
subthreshold antigen stimulation in the presence of self MHC 
class II molecules. In contrast N-acetylprocainamide (the 
metabolites of procainamide) and phthalazine (the parent 
compound of hydralazine that lacks the hydrazine side chain), 
which do not induce lupus, were much less potent in their ability 
to induce T cell autoreactivity (31). Similarly, D10 cells made to 
overexpress LFA-1 or CD49d demonstrated autoreactive 
proliferation against syngeneic antigen presenting cells (Fig. 2). 
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Overexpression of CD18, but not CD49d, induces 
macrophage apoptosis 
 
Interestingly, the LFA-1 overexpressing T cells also killed 
syngeneic macrophages by apoptosis (27-29), likely involving the 
TNF-related apoptosis-inducing ligand (TRAIL, Apo2 ligand) 
and TNF-like weak inducer of apoptosis (TWEAK, Apo3 ligand) 
(32). In contrast, although CD49d transfected D10 cells exhibited 
similar proliferation in response to antigen presenting cells as 
CD18 transfected cells they were unable to induce apoptosis in 
the target cells. This is consistent with reports that LFA-1, but 
not CD49d, has an important role in modulating T cell cytotoxic 
functions (33-36). Increased monocyte apoptosis has been 
reported in lupus patients and it has been proposed that if this 
occurs in the appropriate lymphoid organ such as the spleen it 
may provide a source of antigenic nucleic acids that contributes 
to the autoimmune process in these patients (32). The lack of 
cytotoxicity of CD49d compared to CD18 integrin may therefore 
impact the ability of autoreactive T cells to induce autoimmune 
disease. 
 
Autoreactive proliferation in LFA-1 and CD49 
overexpressing D10 cells is due to overstabilization 
of TCR-Ia interaction 
 
Potential mechanisms linking integrin overexpression to T cell 
autoreactivity include transmission of an increased costimulatory 
signal, overstabilization of normally low affinity TCR-MHC class 
II interaction, or both. A role for increased T cell costimulation 
was tested by culturing control and transfectants with anti-CD3 
and anti-CD11a antibodies (37). Despite minimal calcium fluxes, 
increased protein tyrosine phosphorylation was observed in both 
CD18 and CD49d transfectants (26, 37). The proliferation 
response to graded amounts of these antibodies was identical in 
both cell lines suggesting that increased signaling alone is 
insufficient to cause the increased responsiveness (37). When co-
cultured with syngeneic macrophages the transfectants but not 
the control cells down-regulated TCR expression, thus 
demonstrating successful TCR signaling to a low affinity 
interaction (37). 
 
In vivo autoimmunity is induced by LFA-1- but not 
CD49d- overexpressing D10 cells 
 
Non-irradiated syngeneic (AKR) mice receiving 5-azacytidine or 
procainamide treated D10 cells developed a severe immune 
complex glomerulonephritis, pulmonary alveolitis, central 
nervous system abnormalities including fibrinoid necrosis, 
karyorrhexis, and meningitis, and bile duct proliferation with 
periportal inflammatory cell infiltration resembling primary 
biliary cirrhosis (Fig. 3). Anti-ssDNA, anti-dsDNA, and anti-
histone antibodies were also found (25, 27-29). In contrast, mice 
receiving N-acetylprocainamide and phthalazine did not develop 
any disease (31). Similar to other lupus autoimmunity models 
such as the MRL/lpr and NZB/NZW mice, female mice 
receiving the drug-treated T cells also developed a more severe 
disease with high titers of autoantibodies than male mice (30). 
Additionally, splenectomized mice receiving the drug-treated D10 
cells also did not develop autoantibodies or other features of 
autoimmune disease (30). This suggests that the ability of LFA-1 
overexpressing T cells to induce autoimmune disease may be 
dependant on the ability of the transferred T cells to interact with 
immune cells in the spleen. Interestingly, AKR mice receiving the 
CD18 (25) but not the CD49d transfectants (26) developed 
autoantibodies, immune complex glomerulonephritis and 
pulmonary alveolitis, similar to mice receiving the drug-treated 
cells. Human patients with systemic lupus erythematosus have 
also recently been shown to have T cell subsets that overexpress 
LFA-1 and are autoreactive (9, 10). Taken together, these results 
support a direct role of T cell LFA-1 overexpression in the 
induction of both human and murine autoimmunity. 
 
T cell CD49d overexpression causes increased 
binding to endothelial cell in vitro 
 
Our results showed that although both CD18 and CD49d 
overexpression induced T cell autoreactive proliferation, only the 
CD18 overexpressing T cells are capable of inducing in vivo 
autoimmunity. To confirm that inducing T cell CD49d 
overexpression by transfection has functional consequences, we 
performed both static and flow adhesion assays using control 
D10 and Cd49d transfectants (26). Under static condition, 4 
times more CD49d transfectants were found to adhere to TNF-
stimulated endothelial cells compared with untransfected D10 
cells (p < 0.01). The increased adhesion was reversed with the 
addition of anti-CD49d but not anti-β7 or CD29 antibodies. 
Binding of CD49d transfectant under high (physiological) flow 
rate (2.0 dyne/cm2) was similar to untransfected D10 cells. 
However, a 4-fold increase in binding to endothelial cells was 
observed under low flow condition (0.2 dyne/cm2) (p < 0.01). 
These results are consistent with the notion that α4 integrin is 
involved in the firm adhesion of leukocytes to vascular 
endothelial cells, and less in the initial contact or rolling stage of 
the interaction. 
 
Effect of LFA-1 and CD49d overexpression on in 
vivo T cell splenic homing 
 
CD18 and CD49d overexpression induced T cell autoreactivity. 
However, only the CD18 overexpressing T cells are capable of 
inducing in vivo autoimmunity. Splenectomy also prevented the 
LFA-1 overexpressing cells from causing autoimmune disease. It 
is therefore possible that T cell CD49d overexpression may cause 
decreased splenic homing by directing the CD49d transfectants 
to mucosal or other lymphoid organs. This may in turn protect 
the recipients from developing autoimmune disease. We 
therefore examined the effect of CD18 and CD49d expression 
on in vivo T cell homing. This was initially done by injecting 
CMFDA-labeled control D10 cells, procainamide-treated D10 
cells or CD49d- transfectants into AKR mice. The number of 
CD4+ CMFDA+ cells in the spleens of the recipient mice was 
then determined by flow cytometric analysis 24 hours later. The 
results showed that LFA-1 overexpressing T cells have similar 
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splenic homing as control D10 cells (31). In contrast, CD49d 
transfectants were found to traffic to the spleen 3-4 times more 
than the control D10 cells (p < 0.05) (Fig. 4). To exclude the 
possibility that the observed increased CD49d splenic homing is 
the result of unintended differences in the number of cells given 
to individual animal in the adoptive transfer process, AKR mice 
were given an intravenous mixture of either 5x106 CFDA-SE 
(green)-labeled D10 cells and 5x106 PKH26 (red)-labeled CD49d 
transfectants, or 5x106 CFDA-SE-labeled CD49d transfectants 
and 5x106 PKH26-labeled D10 cells. Mice receiving the CFDA-
SE-labeled D10 cells and PKH26-labeled CD49d transfectants 
were found to have significantly more CD49d transfectants in the 
spleen compared to those receiving the untransfected D10 cells 
(p < 0.001). Similarly mice receiving the PKH26-labeled D10 
cells and CFDA-SE-labeled CD49d transfectants were found to 
have significantly increased D10/CD49d splenic homing (p < 
0.001). Taken together, these results showed that the differential 
ability of LFA-1- and CD49d-overexpressing T cells to induce in 
vivo autoimmunity is unrelated to their ability to traffic to the 
spleen. 
 
Effect of gender on T cell splenic homing is 
estrogen dependent 
 
Female mice had worse disease than male mice in our murine T 
cell adoptive transfer model of autoimmunity. In addition, 
splenectomy abrogated the autoimmune disease in mice receiving 
the autoreative T cells (30). We therefore sorted to determine if 
there was a difference in T cell splenic homing between male and 
female mice. Initial experiment was done by injecting CMFDA-
labeled D10 cells into male and female mice and enumerating the 
number of CD4+CMFDA+ T cells in the spleen (30). The 
results showed a 2 to 7 fold increased T cell splenic homing in 
female compared to male mice (p < 0.01), even after correcting 
for gender difference in body and organ weights. We next 
examined the effects of hormone supplementation by implanting 
17β-estradiol, progesterone or placebo pellets into 
oophorectomized female AKR mice. Similar splenic homing 
experiments were then performed using CMFDA-labeled D10 
cells (38). The 17β-estradiol treated mice had a 2.5 fold increase 
(p=0.043) in splenic homing vs control and a 3.5 fold increase 
(p=0.032) vs progesterone, indicating that estrogen is the 
hormone primarily responsible for the increased splenic homing 
in female mice. 
 
CONCLUSIONS 
 
In this report we describe the methods we used to characterize 
this murine model of autoimmunity based on T cell intergrin 
overexpression. We showed that inducing LFA-1 overexpression 
by treatment with DNA demethylating agents or by transfection 
with either CD18 or CD49d was sufficient to induce T cell 
autoreactive proliferation in a MHC class II specific fashion. In 
addition we showed that CD18, but not CD49d, is involved in 
the killing of syngeneic macrophages. This provides a potential 
mechanism explaining the lack of ability of CD49d 
overexpressing T cells to induce in vivo autoimmune disease in 
mice compared to LFA-1 overexpressing T cells. Our works also 
showed that selected drugs that are known to cause lupus in 
humans may do so by inducing T cell DNA hypomethylation and 
LFA-1 overexpression. This may have implications for idiopathic 
lupus as well since similar findings of T cell DNA 
hypomethylation, LFA-1 overexpression and autoreactivity have 
been shown in lupus patients. Finally, the effects of estrogen on 
T cell splenic homing may provide a rationale for the worse 
clinical course of autoimmune diseases in females. 
 
It is widely accepted that both genetic and environmental factors 
are important in the pathogenesis of autoimmune diseases 
including systemic lupus erythematosus. Unlike most of the 
currently available animal models of human lupus that are 
genetically based, the system described above represents the first 
murine model of environmentally-induced autoimmunity. Over 
100 drugs have now been implicated in drug-induced 
autoimmunity and the list is growing (39). This system may 
potentially be used to test the ability of new drugs to induce 
lupus, such as in pre-clinical trials. The specific inciting agent and 
the cells responsible for the induction of autoimmunity are 
known in this model. This should allow us to dissect out the host 
factors that influence the expression of autoimmunity in vivo as 
well.  
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TABLE AND FIGURES 
 
Questions Asked Experimental Techniques Summary of Results 
Can non-transformed T cells be 
made to over-express cell surface 
integrins? 
Drug-treatments with DNA 
hypomethylating agents; flow 
cytometry, 2D-protein gel; 
electroporation; Southern blots 
Hypomethylated T cells over-express LFA-1. T cells 
transfected with CD11a or CD18 overexpress cell surface LFA-
1. D10 cells transfected with CD49d over-express 
CD49d/CD29 
Does integrin overexpression 
induce T cell autoreactive 
proliferation? 
T cell proliferation assay Both LFA-1 and CD49d overexpression cause T cells to 
proliferate in response to subthreshold amount of antigen in 
the presence of antigen presenting cells. Integrin 
overexpressing T cells lose the requirement for antigen to 
proliferate, and will response to MHC Class II molecules alone 
Does integrin overexpression 
induce T cell cytotoxicity? 
T cell cytotoxicity assay; 
electron microscopy 
LFA-1-overexpressing T cells will kill syngeneic macrophages 
by apoptosis without antigen. In contrast, CD49d 
overexpressing T cells are not cytotoxic 
Is the integrin-induced 
autoreactive proliferation due to 
increased costimulatory signal or 
overstabilization of TCR-MHC 
class II interaction? 
Western blots; calcium flux; 
TCR expression by flow 
cytometry in the presence of 
blocking antibodies 
T cell LFA-1 and CD49d overexpression are associated with 
increased protein tyrosine phosphorylation despite minimal 
calcium flux. Successful TCR signaling occurs despite low-
affinity interactions 
Does integrin overexpression 
induce in vivo autoimmunity? 
T cell adoptive transfer; 
ELISAs for autoantibody 
measurements; urinalyses; 
H&E, immunofluorescence 
staining of tissues 
LFA-1 over-expressing T cells induced in vivo autoimmune 
disease (kidneys, lungs, liver and brain) in syngeneic mice. In 
contrast, CD49d overexpressing T cells are incapable of 
causing autoimmune disease 
Does T cell splenic homing play a 
role in the induction of 
autoimmunity in this model? 
Adoptive transfer of T cells 
into control and 
splenectomized mice 
Splenectomized mice receiving the LFA-1 overexpressing T 
cells do not develop in vivo disease 
Is the lack of the ability of CD49d 
overexpressing T cells to induce in 
vivo disease secondary to poor T 
cell adhesion function? 
Static and flow adhesion assays CD49d overexpressing T cells demonstrated increase binding 
to endothelial cells in static adhesion assays. Increase binding of 
the CD49d transfectants to endothelial cells also occurs under 
low flow condition 
Can the lack of in vivo disease in 
mice receiving the CD49d 
transfectants be explained by 
differential splenic homing? 
T cell trafficking experiments 
using control and transfected T 
cells labeled with Cr51 or cell 
tracker dyes 
CD49d-overexpressing T cells demonstrated increased splenic 
homing. The lack of in vivo disease therefore can not be 
explained by reduced splenic homing of the transfected cells 
What is the role of gender in this 
autoimmunity model? 
Adoptive transfer of T cells 
into control and castrated male 
and female mice 
Oophorectomized female mice develop lower titer of 
autoantibodies and a less severe autoimmune disease 
Does gender or estrogen affect T 
cell splenic homing? 
T cell trafficking experiments 
using male, female, castrated 
female mice with/without 
hormone supplementation 
Female mice have 2-7 fold increased T cell splenic homing. 
Estrogen, but nor progesterone, increases T cell splenic homing 
in oophorectomized mice 
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Fig. 1: A. Southern blot analysis of CD49d tranfected D10 cells. DNA from the pSub2-CD49d construct (a), untransfected D10 cells (b) and subcloned CD49d 
transfectants (c) were digested with Not1, fractionated by agarose gel electrophoresis, transferred to nylon filters and hybridized with the full length CD49d cDNA. The 
full length CD49d cDNA in the transfectant and the pSub2-CD49d construct is identified by the 4.0 kb band. B. CD49d transfectants (filled in circle with arrow 
pointing down and to the left) and untransfected D10 cells (arrow with small head) were stained with anti-CD3, -TCR, -CD18, -CD28, -CD29, -β7, -CD49d and -
CD62L monoclonal antibodies. The x-axis represents fluorescence intensity on an arbitrary scale, and the y-axis represents cell number. C. CD49d transfectants and 
D10 cells stained with anti-CD49d/β7 antibodies (DATK32) or isotype-matched antibodies (arrow with large head). (Ref. 26; Copyright 2003. The American Association of 
Immunologists, Inc.). 
 
 
Fig. 2: CD49d overexpression causes autoreactivity in D10 cells. A. 
Autoreactive proliferation of CD18 transfectants, three different CD49d clones 
(16, 29, 39) and untransfected D10 cells were compared. B. The antigen 
proliferation response of untransfected (D10) and CD49d transfected (Clone 29) 
D10 cells showing that the CD49d transfectants will proliferate in the presence of 
suboptimal concentrations of antigen (conalbumin). C. Autoreactive proliferation 
response of untransfected and CD49d transfected D10 cells in the presence of the 
indicated number of irradiated splenocytes. Effects of saturating amount (10 µg/ml 
final concentration) of functional antibody blockade on the antigen (D) and 
autoreactive (E) proliferation responses of CD49d transfected D10 cells. The 
results represent the mean + SEM of quadruplicate determinations. (Ref. 26; 
Copyright 2003. The American Association of Immunologists, Inc.). 
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Fig. 3: Representative tissue sections from mice receiving the LFA-1 
overexpression D10 cells. A. IgG immunofluorescence staining of a kidney 
section showing IgG immune complex deposition in a mesangial pattern (X100). 
B. H&E staining of kidney section showing severe glomerulonephritis and 
mononuclear cell infiltration (X230). C. Brain in an affected mice showing bland 
thrombosis in a small intracerebral vessel (X150). D. Brain section of an affected 
mouse showing menningeal vessel thrombosis (X150). E. Lung tissue showing 
severe pneumonitis (X200). F. Gross specimen of liver with bile duct dilatation and 
proliferation. G. Lung tissue of a control mouse with normal lung architecture 
(X200). H. H&E staining of liver tissue showing periductal inflammatory cell 
infiltration (X200). 
 
 
Fig. 4: D10 CD49d overexpression causes increase in vivo splenic homing. A. 5 x 106 CMFDA-labeled D10 or CD49d transfectants were injected intravenously 
into 9 AKR mice. The spleen cells were harvested 24 hours later and the percent CMFDA positive cells enumerated by flow cytometric analysis. The results showed 
significantly more CD49d transfectants homed to the spleen (P < 0.05). The results are expressed as percentage of spleen cells that are CMFDA positive. Four AKR mice 
were given 5 x 106 CFDA-SE-labeled D10 cells and 5 x 106 PKH26-labeled CD49d transfectants and the spleens are harvested 24 hours later. Significantly greater 
number of CD49d transfectants was found to home to the spleen (B) (P < 0.001).The results are expressed as the number of CFDA-SE positive or PKH26 positive 
events per 100,000 events during the flow cytometric studies. (Reference 26; Copyright 2003. The American Association of Immunologists. Inc.). 
 
